CQDM funds the development of a novel artificial intelligence tool for cardiovascular clinical trials
Home > Press room > CQDM funds the development of a novel artificial intelligence tool for cardiovascular clinical trials
Copied link!
Share
November 5, 2020
─
A collaboration between Perceiv AI, DalCor Pharmaceuticals and the Montreal Heart Institute
The CQDM is pleased to announce the launch of a $600,000 collaborative project in biopharma and artificial intelligence (AI) to develop an AI-driven precision medicine tool.
the project supports the development of AI-driven digital biomarkers to identify patients who would specifically benefit from given medicines being tested in cardiovascular disease clinical trials.
find out more by visiting the Institute’s websitePress Room
September 6, 2024The 24th edition of the Bal des Grands Cœurs raised $1,401,000 for the Montreal Heart Institute Foundation
June 17, 2024A historic $140 million bequest to the benefit of our community
December 6, 2023The Right Honourable Brian Mulroney and Mrs. Mila Mulroney donate $1.5 million to support the foundations of two hospitals and a research institute